VAR News and Press, Varian Medical Systems Inc. From 03/16/20

PALO ALTO, Calif. , March 16, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced its Halcyon ™ 2.0 treatment system has been approved by the China National Medical Products Administration (NMPA), which allows the company to market this cancer treatment system in China . This...

PALO ALTO, Calif. , March 11, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced that the procurement representative of the Quebec government, Groupe d'Approvisionnement Commun de l'Est du Québec (GACEQ), filed a notice of intent to award a sole source contract to Varian ...

PALO ALTO, Calif. , March 10, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced Medisch Spectrum Twente Hospital in The Netherlands , and Icon Cancer Centre Wahroonga and Royal North Shore Hospital (RNSH) in Australia treated their first patients with Ethos ™ therapy. Thi...

Citing delays in hardware and software installations and acceptance as well as deliveries of interventional oncology procedures due to COVID-19, Varian (NYSE: VAR ) has trimmed its fiscal Q3 revenue forecast to $800M - 825M versus consensus of $873.2M. More news on: Varian Medical System...

PALO ALTO, Calif. , March 9, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced that the COVID-19 outbreak will negatively impact the company's operating results. Across the company's Asia-Pacific geographies, healthcare resources are being prioritized for the treatment and...

Abbott (NYSE: ABT ) resumed with Neutral rating and $96 (8% upside) price target at Goldman Sachs. Shares down  1%  premarket. More news on: Abbott Laboratories, Baxter International Inc., Boston Scientific Corporation, Healthcare stocks news, Stocks on the move, , Read more ...

Varian Medical Systems ( VAR ) has received FDA 510(k) clearance for its Ethos therapy, an Adaptive Intelligence solution. More news on: Varian Medical Systems, Inc., Healthcare stocks news, Read more ...

PALO ALTO, Calif. , Feb. 11, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has received FDA 510(k) clearance for its Ethos ™  therapy, an Adaptive Intelligence ™  solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution that ...

Aimmune Gets a Boost as FDA Green Signals Allergy Medication Aimmune Therapeutics ( AIMT ) received FDA nod for its peanut allergy medication Palforzia. This orally administered medication aims to mitigate allergic reactions caused by exposure to peanuts. While it is not designed to be an ...

Varian Medical Systems   (NYSE: VAR) has been on a roll over the last five months, with its shares soaring 36%. The medical device maker's solid fiscal 2019 fourth-quarter results in October helped keep that roll going. But that momentum was put to the test when Varian announced its fi...